Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Gilles Lemesle

PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies
Jul 12, 2026, 06:42 | Blog
PERT-Guided Patient Selection for Advanced Pulmonary Embolism Therapies
Pulmonary embolism (PE) remains one of the most challenging cardiovascular emergencies, requiring rapid diagnosis, accurate…
Abdul Mannan: What Is the Most Common “Freeloading” Medication Seen in Anticoagulated Patients?
Jun 5, 2026, 01:54 | Voices
Abdul Mannan: What Is the Most Common “Freeloading” Medication Seen in Anticoagulated Patients?
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn…
Mital Jhaveri: Do Heart Failure Patients on Anticoagulants Still Need Aspirin?
May 21, 2026, 12:38 | Science
Mital Jhaveri: Do Heart Failure Patients on Anticoagulants Still Need Aspirin?
Mital Jhaveri, Clinical Anticoagulation, Heart Failure Pharmacist at NYC HHC Queens Hospital Center, shared a…
Gilles Soulat: Low-Dose Rivaroxaban Plus DAPT for LV Thrombus Prevention After Anterior STEMI
Mar 9, 2026, 15:30 | Voices
Gilles Soulat: Low-Dose Rivaroxaban Plus DAPT for LV Thrombus Prevention After Anterior STEMI
Gilles Soulat, Professor of Radiology at Paris Cité University, shared a post  on LinkedIn about a…
Ney Carter Borges: The APERITIF Trial Clarifies Rivaroxaban's Role in LVT
Feb 26, 2026, 14:48 | Science
Ney Carter Borges: The APERITIF Trial Clarifies Rivaroxaban's Role in LVT
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared on…
Babak Alex Vakili: Net Clinical Benefit Favors OAC Alone, According to the AQUATIC Trial
Nov 7, 2025, 01:34 | Insight
Babak Alex Vakili: Net Clinical Benefit Favors OAC Alone, According to the AQUATIC Trial
Babak Alex Vakili, President and CEO at Heart Vein and Vascular Clinic, shared on LinkedIn:…
AQUATIC Trial: Validates Stopping ASA Improves Safety and Efficacy in CAD
Sep 22, 2025, 12:43 | Science
AQUATIC Trial: Validates Stopping ASA Improves Safety and Efficacy in CAD
Christopher Cannon, Editor in Chief, Harvard Health Publishing, shared a post on LinkedIn: "Very important…
Abdulla A. Damluji: Early Aspirin Discontinuation After PCI Safe in Low-Risk Heart Attack Patients – TARGET-FIRST Trial
Sep 1, 2025, 07:16 | Science
Abdulla A. Damluji: Early Aspirin Discontinuation After PCI Safe in Low-Risk Heart Attack Patients – TARGET-FIRST Trial
Abdulla A. Damluji, Director of the Cardiovascular Center on Aging at Cleveland Clinic, has shared…
NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome
Aug 31, 2025, 10:55 | Science
NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X: ”Aspirin in Patients…
All: 9 Posts: 1 - 100
NewsFeed